Clinical Trial: Ultrasound Guided Local Infiltration Analgesia for Hip Arthroscopy

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: Comparison of Bupivacaine to Liposomal Bupivacaine for Ultrasound Guided Periarticular Hip Infiltration for Postoperative Analgesia After Hip Arthroscopy.

Brief Summary: This study is being undertaken to compare the pain control using either bupivacaine versus liposomal bupivacaine. Liposomal bupivacaine can potentially provide pain relief lasting up to 72 hours while regular bupivacaine can provide pain relief up to 12 hours

Detailed Summary: Patients undergoing hip arthroscopy experience moderate to severe postoperative pain. Effective pain control after surgery is an important component in the overall management of these patients. Good pain control encourages early participation in rehabilitation program, increases success of the surgery, and improves patient satisfaction. Typically, postoperative analgesia is provided to these patients either with nerve blocks or opioid medications. Both these methods provide good pain relief but nerve blocks are associated with weakness of lower extremity muscles which interferes with early ambulation and increase the risk of falls while narcotic medications increase the risk of nausea, vomiting, itching, constipation, ileus, urinary retention, sedation and respiratory depression.
Sponsor: Saint Francis Care

Current Primary Outcome: Opioid consumption [ Time Frame: 96 hours after surgery ]

Opioid consumption will be reviewed at 96 hours after surgery.


Original Primary Outcome: Same as current

Current Secondary Outcome: Pain Scores [ Time Frame: 96 hours after surgery ]

Analysis of pain scores (at rest and ambulation) during hospital stay.


Original Secondary Outcome: Same as current

Information By: Saint Francis Care

Dates:
Date Received: June 28, 2013
Date Started: July 2013
Date Completion: December 2017
Last Updated: March 7, 2017
Last Verified: March 2017